Research Guide
Endogenous

DSIP

Delta sleep-inducing peptide studied for sleep regulation, stress adaptation, and neuroendocrine modulation.

Overview

DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide first isolated from cerebral venous blood of rabbits during induced sleep. It has been studied for its effects on sleep architecture, stress response, pain modulation, and neuroendocrine regulation.

The following information summarizes peer-reviewed research on DSIP. Study descriptions reflect published findings, e.g., "animal studies have investigated," "cellular studies suggest," or "clinical trials have evaluated", and do not constitute therapeutic claims.

Mechanism of Action

DSIP modulates sleep architecture by enhancing slow-wave (delta) sleep. It acts on multiple systems including opioid pathways, GABA, and hypothalamic releasing hormones. It inhibits somatostatin release, modulates corticotropin levels, and has been shown to normalize circadian rhythm disruptions.

GABAergic Modulation

Research Evidence

PSI Research Evidence Profile

DSIP. Evidence Summary

Last updated 1985
Insufficient evidence for conclusions

Too few studies to assess evidence strength

Evidence Level 1: Early Research, Very limited published research. May include only 1–2 preliminary laboratory or theoretical studies.

2Total

Study Type Distribution

Human
0
Animal
1
Cell
0
Reviews
1

17

Human Studies

165

Animal Studies

0

In Vitro

18

Reviews

4

Last 5 Years

8

Last 10 Years

518

Total Indexed Studies

Research Timeline

Chronological progression of DSIP research, auto-generated from 5 indexed publications.

1984
Discovery

Delta sleep-inducing peptide (DSIP): an update

Peptides

Comprehensive review of DSIP neuromodulatory effects on sleep architecture and stress response.

1984
Discovery

Graf & Kastin (1984). Comprehensive review of DSIP's neuromodulatory effects.

Research on DSIP

1984
Discovery

Larbig et al. (1984). Demonstrated analgesic properties in chronic pain patients.

Research on DSIP

1985
Recent

Effects of DSIP on insomnia: a clinical study

European Neurology

Clinical study showing improved sleep quality in chronic insomniacs treated with DSIP.

1985
Recent

Schneider-Helmert (1985). Clinical study showing improved sleep in chronic insomniacs.

Research on DSIP

Conditions Studied

Research Studies

2 studies
Research summary last updated: 2003

Delta sleep inducing peptide (DSIP): an update

Kovalzon VM, Strekalova TV

Peptides, 2003

animal
PubMed Indexed

Comprehensive review of DSIP's sleep-modulatory, stress-protective, and analgesic effects across multiple animal and human studies.

Stress-modulatory peptide affecting sleep architecture and HPA axis
PubMed

DSIP promotes sleep and reduces opioid withdrawal symptoms

Dick P, Grandjean ME, Bhatt A et al.

European Journal of Pharmacology, 1989

human
PubMed IndexedPeer Reviewed

DSIP administration improved sleep quality and reduced withdrawal severity in patients undergoing opioid detoxification.

Endogenous opioid system modulation and sleep regulation
PubMed

Study Highlights

Delta sleep-inducing peptide (DSIP): an update

Graf MV, Kastin AJ. · Peptides, 1984

Comprehensive review of DSIP neuromodulatory effects on sleep architecture and stress response.

Effects of DSIP on insomnia: a clinical study

Schneider-Helmert D. · European Neurology, 1985

Clinical study showing improved sleep quality in chronic insomniacs treated with DSIP.

References

2 peer-reviewed publications referenced in this DSIP research overview. 2 linked to PubMed or DOI.

Review: 1Human Study: 1
  1. [1]

    Delta sleep-inducing peptide (DSIP): an update

    Graf MV, Kastin AJ.

    Peptides

    PubMedDOIView on PubMed

Scientific Context

This page summarizes published scientific research on DSIP. Many peptides discussed on this site are experimental research compounds that have not been approved for clinical use. The research presented here is sourced from peer-reviewed journals and indexed databases such as PubMed. Evidence levels and study counts reflect the quantity and type of available research, not efficacy or safety endorsements.

This content is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making any health-related decisions.

Learn about our editorial standards →

Research Transparency

PSI functions as a transparent research index. All research information is sourced from peer-reviewed scientific literature and automatically indexed from PubMed/MEDLINE. Every study displayed includes verifiable source references. PubMed ID, journal, authors, and publication year, allowing independent verification. PSI does not make therapeutic claims; all content summarizes published research findings.

Looking for a physician who prescribes this peptide? Browse the PSI physician directory →

Published: January 15, 2025

Updated: March 1, 2026

This content is for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Consult a qualified healthcare provider before making any health decisions.